KOL Perspectives: Adaptive Trial Designs in IBD [Report Updated: 22082018] Prices from USD $2125

04:41 EST 29 Nov 2018 | BioPortfolio Report Blog

KOL Perspectives: Adaptive Trial Designs in IBD


This KOL Insight briefing focuses on KOLs views of Adaptive trial designs in IBD.

Questions topics

Current challenges in IBD clinical trials

Adaptive Phase II/III trial designs

Guselkumab's Phase II/III trial in Crohn's disease

Novel clinical trials in IBD

Key Highlights

Most KOLs highlighted that recruitment is the greatest challenge in IBD clinical trials, both across Crohn's disease UC

Most KOLs flagged Phase II/III trials could accelerate development, but may limit ability to analyze data adapt trial design

Most KOLs cited 812 weeks as being the minimum duration of a Phase II trial in IBD, with openlabel extensions favored by all KOLs.


The insight briefing is based on Sociable Pharma's analysis of primary research with our IBD key opinion leaders KOLs.

In total, we conducted interviews with 10 KOLs

5 Europebased 5 N. Americabased

Interviews performed during July 2018

KOL data is analyzed to produce

Charts summarizing KOL opinions

Chart callouts of key information details

KOL quotes

Summary of KOL reporting trends

Insight from Sociable Pharma's analysts

Reasons to buy

Combines Qualitative semiquantitative insight from key opinion leaders on Adaptive trial designs in IBD

Includes insight recommendations from our diseasespecific healthcare analysts

Utilizes independent expert viewpoints to validate the impact of new clinical data emerging trends on management of IBD

Provides costeffective support for your advisory boards, with topics acting as a catalyst for further expert discussion.

Original Article: KOL Perspectives: Adaptive Trial Designs in IBD [Report Updated: 22082018] Prices from USD $2125


More From BioPortfolio on "KOL Perspectives: Adaptive Trial Designs in IBD [Report Updated: 22082018] Prices from USD $2125"

Quick Search

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...